19 min listen
Quantitative assessment of residual pancreatic intraductal carcinoma following neoadjuvant chemotherapy
FromModPath Chat
Quantitative assessment of residual pancreatic intraductal carcinoma following neoadjuvant chemotherapy
FromModPath Chat
ratings:
Length:
16 minutes
Released:
Sep 29, 2020
Format:
Podcast episode
Description
Modern Pathology Editor in Chief discusses with Laura Wood MD PhD her recent study on quantitative assessment of residual pancreatic intraductal carcinoma following neoadjuvant chemotherapy. The implications of finding that the intraductal component of pancreatic cancer is more resistant to chemotherapy are highlighted. Study by Fujikura et al, Intraductal pancreatic cancer is less responsive than cancer in the stroma to neoadjuvant chemotherapy. Modern Pathology, 2020. https://www.nature.com/articles/s41379-020-0572-6 Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.
Released:
Sep 29, 2020
Format:
Podcast episode
Titles in the series (58)
COVID-19 pulmonary pathology in cross Atlantic pandemic epicenters: A discussion with Dr. Borczuk of New York Presbyterian Hospital- Weill Cornell Medicine on his team findings in sixty eight COVID-19 autopsies, performed early on during the pandemic, at 3 institutions in heavily hit areas (2 USA, 1 Italy). by ModPath Chat